Cubist Systematic Strategies, LLC Otonomy, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.31 $15,362 - $20,997	-9,090 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.22 - $2.2 $17,721 - $31,957	-14,526 Reduced 61.51%	9,090 $17,000
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.67 $22,833 - $29,594	11,084 Added 88.45%	23,616 $53,000
Q1 2021 May 17, 2021	SELL	$2.49 - $6.23 $37,270 - $93,250	-14,968 Reduced 54.43%	12,532 $32,000
Q4 2020 Feb 16, 2021	BUY	$3.48 - $6.47 $92,693 - $172,334	26,636 Added 3082.87%	27,500 $178,000
Q3 2020 Nov 16, 2020	BUY	$3.16 - $4.36 $2,730 - $3,767	864 New	864 $3,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.